Converging Advances in Reproductive Biomedicine and Stem CellTechnology: Reflections from The 25th and 20thRoyan Congresses: A Commentary
نویسندگان
1 Department of International Education, Deputy of Education, Royan Institute, ACECR, Tehran, Iran
2 Department of International Education, Deputy of Education, Royan Institute, ACECR, Tehran, Iran
3 Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
4 Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
5 Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
6 Department of International Education, Deputy of Education, Royan Institute, ACECR, Tehran, Iran
7 Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Iran, Tehran
8 Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
9 Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
doi
10.22074/cellj.2026.2084389.2006چکیده
The 25th International Congress on Reproductive Biomedicine and the 20th International Congress on Stem Cell Biologyand Technology, held in Iran, brought together leading global experts to discuss pioneering advances in stem cellresearch and reproductive medicine. Key topics included recent progress in somatic and pluripotent stem cells towardclinical applications, developments in regenerative medicine for diverse diseases, innovations in tissue engineering, theintegration of artificial intelligence (AI) in biology research, and novel strategies for treating infertility. The congressesfostered collaboration and knowledge exchange across these rapidly evolving fields, highlighting the transformativepotential of stem cells in regenerative medicine and their applications in reproductive health. Participation of 33scientists from the United States, the United Kingdom, Germany, Austria, Italy, Belgium, Turkey, China, Russia, Japan,Sweden, Switzerland, Qatar, and India facilitated a rich exchange of ideas and broadened international perspectives.The insights and outcomes from these congresses are expected to shape ongoing research initiatives and clinicalpractices worldwide, emphasizing the importance of continued investment in these critical areas of medicine.
